Bo-Wen Lin

Glycemic control with empagliflozin, a novel selective SGLT2 inhibitor, ameliorates cardiovascular injury and cognitive dysfunction in obese and type 2 diabetic mice

Bo-Wen Lin, Nobutaka Koibuchi, Yu Hasegawa et al. · Cardiovascular Diabetology · 2014 · 403 citations · Full text

Overexpression of Pyruvate Dehydrogenase Kinase 3 Increases Drug Resistance and Early Recurrence in Colon Cancer

Chun-Wun Lu, Shau-Chieh Lin, Chun-Wei Chien et al. · American Journal Of Pathology · 2011 · 138 citations · Full text

High‐Fat‐Diet Intake Enhances Cerebral Amyloid Angiopathy and Cognitive Impairment in a Mouse Model of Alzheimer's Disease, Independently of Metabolic Disorders

Bo-Wen Lin, Yu Hasegawa, Koki Takane et al. · Journal of the American Heart Association · 2016 · 107 citations · Full text

LCZ696, Angiotensin II Receptor-Neprilysin Inhibitor, Ameliorates High-Salt-Induced Hypertension and Cardiovascular Injury More Than Valsartan Alone

Hiroaki Kusaka, Daisuke Sueta, Nobutaka Koibuchi et al. · American Journal of Hypertension · 2015 · 72 citations · Full text

Regulation of CD151 by Hypoxia Controls Cell Adhesion and Metastasis in Colorectal Cancer

Chun-Wei Chien, Shih‐Chieh Lin, Yen-Yu Lai et al. · Clinical Cancer Research · 2008 · 71 citations